Antti Mäkitie, MD, PhD, Professor

MÄKITIE-ANTTI.jpgProfessional title: Head Physician
 
Education: MD 1986, MD PhD 1997, Specialist in ORL-HNS 1994, Docent degree 2004, Diploma in Health Care Administration 2005, all at the Univ. of Helsinki
 
Clinical interests: Head and neck surgery, head and neck surgical oncology, medical applications of additive manufacturing
 
Areas of publications: Head and neck oncology, neoplasms, epidemiology, molecular markers, new treatment modalities, medical applications of additive manufacturing
 
Fellowships and visits: Research and Clinical Fellowship at the University of Toronto 2000-2003, Professor at the Univ. of Turku 2008-2009, Visiting Scientist at the Karolinska Institute 2012- -, Visiting scientist at the Hopital Tenon, Université Pierre et Marie Curie,
Université Paris VI, Sorbonne Universités, Paris 2018-2019.​
 
Memberships: CORLAS (Gen. Secr.),
SSHNO (President), EBE-ORL (Hon. Fellow, Examiner),
IHNSG (Member), Finnish Association of ORL–HNS (Vice President)
 
Supervised PhD theses: 2006, MD Mari Markkanen-Leppänen: Functional outcome after free flap reconstructions in oral and pharyngeal cancer; 2007, MD Harri Keski-Säntti: Evaluation of regional and distant metastases in head and neck squamous cell carcinoma patients; 2008, MSc (tech) Anna-Kaarina Järvinen: Microarrays in molecular profiling of cancer: focus on head and neck squamous cell carcinoma; 2011, MD Roderik Mrena: Investigations of noise-related tinnitus; 2012, MD Katri Aro: Aspects on the management of salivary gland mucoepidermoid carcinoma in Finland; 2012, MD Suvi Renkonen: Factors affecting the variable outcomes of juvenile nasopharyngeal angiofibroma; 2013, MSc (tech) Mika Salmi: Medical applications of additive manufacturing in surgery and dental care; 2013: MD Marie Lundberg: Transforming growth factor beta1 genotype, p16 expression, and treatment outcome in head and neck squamous cell carcinoma; 2014: DDS Ulla Perheentupa: Epidemiology, management and outcome of facial injuries. With Special emphasis on anterior cranial base fractures; 2016: MD Aaro Haapaniemi: Laryngeal cancer recurrence. Prognostic factors and management; 2017: MD Karoliina Hirvonen: Adenoid cystic carcinoma of salivary glands – diagnostic and prognostic factors and treatment outcome; 2018: MD Lauri Jouhi: Oropharyngeal cancer: modern management and role of Toll—like receptors; 2018: MD Johanna Ruohoalho: Complications and their registration in ORL surgery; 2018: MSc, RD Helena Orell: Nutritional status and effect of nutritional counselling in patients with head and neck cancer; 2018: MD Annastiina Husso: Development of reconstructive head and neck surgery – special emphasis on novel applications of microsurgery; 2018: Lic.Sc (tech) Jukka Tuomi: Medical applications of additive manufacturing – application-oriented classification for case design and documentation; 2019: MD Timo Carpén: Oropharyngeal cancer: new clinical and prognostic aspects of HPV-driven disease
; 2019: DDS Hesham Mohamed: Evaluation of prognostic markers for oropharyngeal carcinoma using tissue microarray; 2019: MD Johanna Jokela: Sialendoscopy in the management of benign salivary gland diseases; 2019: MD Annett Szibor: New clinical parameters to improve diagnosis and management of tinnitus
 
Supervision of ongoing Phd theses: DDS Hanna Hämetoja: Adenoid cystic carcinoma of minor salivary glands - diagnostic and prognostic factors and outcome; MD Amy Dickinson: Systems biology in finding novel biomarkers for oral and oropharyngeal cancer; MD Venla Loimu: Oncological treatment of head and neck cancer; MD Anna Mäkinen: Microbiome profile of oral cancer; DDS Rayan Mroueh: Prognostic factors of ​oral cancer; MD Markku Toivonen: Acute acoustic trauma among Finnish conscripts; 
MD Anna Tuhkuri: Systems level analysis of oropharyngeal squamous cell carcinoma - from discovery to diagnostics; MD Teija Nieminen: Value-based health care approach in head and neck cancer management; MD Maria Jauhiainen: Viral etiology in head and neck neoplasms; MSc Katja Tuomainen: Towards personalized treatment of oral squamous carcinoma via improved prognosis and development of novel invasion analysis tools; MD Pauli Vähämurto: Prognostic markers for sinonasal and testis lymphoma